Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

LAXMI DENTAL LTD.

NSE : LAXMIDENTLBSE : 544339ISIN CODE : INE0WO601020Industry : Medical Equipment/Supplies/AccessoriesHouse : Private

BSE490.60-44.65 (-8.34 %)

PREV CLOSE ( ) 535.25

OPEN PRICE ( ) 539.70

BID PRICE (QTY) 490.30 (8)

OFFER PRICE (QTY) 491.05 (148)

VOLUME 165896

TODAY'S LOW / HIGH ( )488.25 548.65

52 WK LOW / HIGH ( )524.8 583.7

NSE490.45-45.25 (-8.45 %)

PREV CLOSE( ) 535.70

OPEN PRICE ( ) 539.40

BID PRICE (QTY) 490.10 (1019)

OFFER PRICE (QTY) 490.45 (153)

VOLUME 3089097

TODAY'S LOW / HIGH( ) 487.85 548.65

52 WK LOW / HIGH ( )525 584

Select year

Particulars

Mar 2024

Mar 2023

Mar 2022

Operational & Financial Ratios

Earnings Per Share (Rs)

804.48

-128.99

-596.27

CEPS(Rs)

10.78

2.36

-3.13

DPS(Rs)

0.00

Book NAV/Share(Rs)

1001.33

200.26

306.53

Tax Rate(%)

-110.48

-4.41

-16.12

Margin Ratios

Core EBITDA Margin(%)

12.86

6.11

4.49

EBIT Margin(%)

7.53

0.46

-7.61

Pre Tax Margin(%)

4.40

-2.64

-10.75

PAT Margin (%)

9.27

-2.75

-12.48

Cash Profit Margin (%)

15.44

4.05

-6.35

Performance Ratios

ROA(%)

16.01

-4.46

-16.65

ROE(%)

96.95

-57.01

-180.94

ROCE(%)

21.79

1.50

-20.54

Asset Turnover(x)

1.73

1.62

1.33

Sales/Fixed Asset(x)

3.12

3.22

2.89

Working Capital/Sales(x)

-34.97

-35.52

293.65

Efficiency Ratios

Fixed Capital/Sales(x)

0.32

0.31

0.35

Receivable days

42.73

46.05

54.32

Inventory Days

46.15

60.66

78.69

Payable days

144.21

214.61

245.23

Valuation Parameters

PER(x)

0.00

PCE(x)

0.00

Price/Book(x)

0.00

Yield(%)

EV/Net Sales(x)

0.27

0.26

0.29

EV/Core EBITDA(x)

1.99

3.46

5.44

EV/EBIT(x)

3.64

55.87

-3.85

EV/CE(x)

0.63

0.85

0.79

M Cap / Sales

0.00

Growth Ratio

Net Sales Growth(%)

19.75

18.11

0.00

Core EBITDA Growth(%)

119.92

64.05

0.00

EBIT Growth(%)

1848.13

107.18

0.00

PAT Growth(%)

503.26

73.96

0.00

EPS Growth(%)

723.66

78.37

0.00

Financial Stability Ratios

Total Debt/Equity(x)

0.99

1.77

1.41

Current Ratio(x)

0.92

1.01

Quick Ratio(x)

0.57

0.50

0.51

Interest Cover(x)

2.41

0.15

-2.42

Total Debt/Mcap(x)